Company Filing History:
2 out of 1,327 
2 out of 15,502 
2 out of 896 
Years Active: 2017-2021
Title: Grace Chan: Innovator in Cancer Treatment
Introduction
Grace Chan is a prominent inventor based in Monterey Park, California. She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. With a total of two patents, her work focuses on the development of cell-penetrating anti-DNA antibodies that have the potential to revolutionize cancer therapies.
Latest Patents
Grace Chan's latest patents include groundbreaking methods for utilizing cell-penetrating anti-DNA antibodies. These antibodies are designed to penetrate cell nuclei and inhibit DNA repair processes. This innovative approach not only targets cancer cells directly but also sensitizes them to DNA-damaging treatments such as chemotherapy and radiation. The method involves treating cells with a composition containing these antibodies, either alone or in combination with treatments that induce DNA damage. The effectiveness of these antibodies is particularly pronounced in cancer cells that are deficient in DNA repair mechanisms, making them synthetically lethal to such cells.
Career Highlights
Throughout her career, Grace Chan has worked with esteemed institutions such as Yale University and the University of California. Her research has garnered attention for its potential to improve cancer treatment outcomes and for its innovative approach to targeting viral infections.
Collaborations
Grace has collaborated with notable colleagues in her field, including James E. Hansen and Peter M. Glazer. These collaborations have further enhanced her research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Grace Chan's innovative work in developing cell-penetrating anti-DNA antibodies represents a significant advancement in cancer treatment. Her contributions to the field highlight the importance of research and innovation in combating complex diseases.